TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Pelago Bioscience AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
58,827
|
55,323
|
53,690 |
Financial expenses |
11
|
36
|
12 |
Earnings before taxes |
-4,755
|
3,833
|
7,281 |
EBITDA |
-3,665
|
7,282
|
10,202 |
Total assets |
61,688
|
47,900
|
44,141 |
Current assets |
41,250
|
37,912
|
30,744 |
Current liabilities |
22,982
|
25,325
|
23,265 |
Equity capital |
38,643
|
20,896
|
19,259 |
- share capital |
77
|
36
|
39 |
Employees (average) |
52
|
51
|
39 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
62.6%
|
43.6%
![]() |
43.6% |
Turnover per employee |
1,131
|
1,085
|
1,377 |
Profit as a percentage of turnover |
-8.1%
|
6.9%
|
13.6% |
Return on assets (ROA) |
-7.7%
|
8.1%
|
16.5% |
Current ratio |
179.5%
|
149.7%
|
132.1% |
Return on equity (ROE) |
-12.3%
|
18.3%
|
37.8% |
Change turnover |
3,219
|
5,982
|
8,027 |
Change turnover % |
6%
|
12%
|
18% |
Chg. No. of employees |
1
|
12
![]() |
12 |
Chg. No. of employees % |
2%
|
31%
|
44% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.